A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Evaluation of survival data and two new rank order statistics arising in its consideration.
1966 • 7,595 citations
Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvis
1979 • 221 citations
Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix
1983 • 117 citations
Chemotherapy of gynecologic cancer
1984 • 66 citations
Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix
1977 • 62 citations
Hydroxyurea and radiation therapy in advanced cervical cancer
1974 • 62 citations
Radiation therapy oncology group clinical trials with misonidazole
1981 • 57 citations
Final report on the united states phase i clinical trial of the hypoxic cell radiosensitizer, misonidazole (RO-07-0582; NSC #261037)
1981 • 51 citations
Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea
1985 • 25 citations
Hydroxy urea and radiation for stages IIIB and IVA cervix cancer analysis of recurrence patterns and radiation factors
1980 • 10 citations